NodThera names Chris Guiffre CFO

Inflammatory disease company NodThera Ltd. named Chris Guiffre CFO. He has held C-suite roles at Auron Therapeutics Inc., Pear Therapeutics Inc. and Cerulean Pharma Inc., and played a role in taking the latter two companies public.

Montai Therapeutics Inc. named Hans Hull COO. He was CBO at Pliant Therapeutics Inc. (NASDAQ:PLRX). Backed by Flagship Pioneering, Cambridge, Mass.-based Montai is using artificial intelligence and chemistry analysis to develop therapies for chronic diseases...